These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 15533354

  • 1. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P.
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [Abstract] [Full Text] [Related]

  • 2. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M.
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [Abstract] [Full Text] [Related]

  • 5. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P.
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M, Skull JD, Ledger WL.
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [Abstract] [Full Text] [Related]

  • 8. Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization.
    Takahashi C, Fujito A, Kazuka M, Sugiyama R, Ito H, Isaka K.
    Fertil Steril; 2008 Mar; 89(3):586-91. PubMed ID: 17543956
    [Abstract] [Full Text] [Related]

  • 9. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
    Aleyasin A, Aghahoseini M, Mokhtar S, Fallahi P.
    Acta Med Iran; 2011 Mar; 49(11):715-20. PubMed ID: 22131240
    [Abstract] [Full Text] [Related]

  • 10. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
    Wunder DM, Bersinger NA, Yared M, Kretschmer R, Birkhäuser MH.
    Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
    [Abstract] [Full Text] [Related]

  • 11. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
    Cupisti S, Dittrich R, Mueller A, Strick R, Stiegler E, Binder H, Beckmann MW, Strissel P.
    Eur J Med Res; 2007 Dec 14; 12(12):604-8. PubMed ID: 18024272
    [Abstract] [Full Text] [Related]

  • 12. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
    Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, Gal M, Zylber-Haran E, Margalioth EJ.
    Hum Reprod; 2005 Nov 14; 20(11):3178-83. PubMed ID: 16113044
    [Abstract] [Full Text] [Related]

  • 13. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ, Yang HY, Lin JJ, Chen X, Ye BL.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr 14; 44(4):260-2. PubMed ID: 19570462
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul 14; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.
    van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Fauser BJ, Themmen AP, te Velde ER.
    Fertil Steril; 2005 Apr 14; 83(4):979-87. PubMed ID: 15820810
    [Abstract] [Full Text] [Related]

  • 19. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
    Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E, Yin L, Matos-Bodden L, Leader B, Stadtmauer L.
    Am J Obstet Gynecol; 2008 Aug 14; 199(2):202.e1-8. PubMed ID: 18674663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.